ICD-10: E72.89

Other specified disorders of amino-acid metabolism

Clinical Information

Inclusion Terms

  • Disorders of gamma-glutamyl cycle
  • Disorders of beta-amino-acid metabolism

Additional Information

Clinical Information

The ICD-10 code E72.89 refers to "Other specified disorders of amino-acid metabolism." This classification encompasses a variety of conditions that affect the metabolism of amino acids, which are the building blocks of proteins and play crucial roles in numerous physiological processes. Understanding the clinical presentation, signs, symptoms, and patient characteristics associated with this code is essential for accurate diagnosis and management.

Clinical Presentation

Patients with disorders of amino-acid metabolism may present with a range of symptoms that can vary significantly depending on the specific disorder involved. Common clinical presentations include:

  • Neurological Symptoms: Many amino-acid metabolism disorders can lead to neurological issues, such as developmental delays, seizures, or cognitive impairments. For instance, conditions like phenylketonuria (PKU) can result in intellectual disability if not managed properly.
  • Metabolic Crises: Some patients may experience acute metabolic crises characterized by vomiting, lethargy, and altered mental status, often triggered by illness, fasting, or dietary indiscretion.
  • Failure to Thrive: Infants and children may exhibit poor growth or failure to thrive due to inadequate protein utilization or dietary restrictions necessary to manage their condition.

Signs and Symptoms

The signs and symptoms associated with E72.89 can be diverse and may include:

  • Gastrointestinal Issues: Symptoms such as nausea, vomiting, and abdominal pain can occur, particularly during metabolic crises.
  • Skin Manifestations: Some disorders may lead to skin rashes or changes in pigmentation due to abnormal amino acid levels.
  • Behavioral Changes: Patients may exhibit behavioral issues, including irritability or changes in mood, often linked to neurological involvement.
  • Muscle Weakness: Myopathy or muscle weakness can be a sign of certain amino-acid metabolism disorders, affecting physical activity and overall strength.

Patient Characteristics

The characteristics of patients with disorders classified under E72.89 can vary widely, but several common factors include:

  • Age of Onset: Many amino-acid metabolism disorders are diagnosed in infancy or early childhood, although some may present later in life.
  • Family History: A positive family history of metabolic disorders is often noted, as many of these conditions are inherited in an autosomal recessive manner.
  • Ethnic Background: Certain disorders may be more prevalent in specific ethnic groups due to genetic factors. For example, PKU is more common in individuals of Northern European descent.
  • Dietary Restrictions: Patients often require strict dietary management to avoid specific amino acids or to ensure adequate intake of essential nutrients, which can impact their overall health and development.

Conclusion

Disorders of amino-acid metabolism, as classified under ICD-10 code E72.89, present a complex array of clinical features that necessitate careful evaluation and management. Recognizing the signs and symptoms, understanding patient characteristics, and implementing appropriate dietary and medical interventions are crucial for improving outcomes in affected individuals. Early diagnosis and ongoing monitoring can significantly enhance the quality of life for patients with these metabolic disorders.

Description

ICD-10 code E72.89 refers to "Other specified disorders of amino-acid metabolism." This classification falls under the broader category of disorders related to amino acid metabolism, which are critical for various bodily functions, including protein synthesis, energy production, and neurotransmitter regulation.

Clinical Description

Overview of Amino Acid Metabolism Disorders

Amino acid metabolism disorders encompass a range of genetic and acquired conditions that affect the body's ability to process amino acids properly. These disorders can lead to an accumulation of toxic metabolites or a deficiency in essential amino acids, resulting in various clinical manifestations. The specific disorders classified under E72.89 are not detailed in other specific codes, indicating that they may present unique clinical features or arise from less common metabolic pathways.

Symptoms and Clinical Presentation

The symptoms associated with disorders of amino acid metabolism can vary widely depending on the specific disorder and the amino acids involved. Common clinical features may include:

  • Neurological Symptoms: These can range from developmental delays and cognitive impairments to seizures and behavioral issues, often due to the accumulation of toxic metabolites affecting brain function.
  • Metabolic Crises: Patients may experience acute metabolic crises characterized by vomiting, lethargy, and hypoglycemia, particularly during periods of stress or illness.
  • Growth and Developmental Issues: Children with amino acid metabolism disorders may exhibit growth retardation or failure to thrive due to inadequate nutrient absorption or metabolic imbalances.
  • Dermatological Manifestations: Some disorders may present with skin rashes or other dermatological symptoms due to metabolic disturbances.

Diagnosis

Diagnosis of disorders classified under E72.89 typically involves a combination of clinical evaluation, biochemical testing, and genetic analysis. Key diagnostic steps include:

  • Blood and Urine Tests: These tests can identify abnormal levels of amino acids or their metabolites, which are indicative of specific metabolic disorders.
  • Genetic Testing: Identifying mutations in genes responsible for amino acid metabolism can confirm the diagnosis and guide treatment options.
  • Clinical History and Physical Examination: A thorough clinical history and physical examination are essential to assess symptoms and family history of metabolic disorders.

Treatment Options

Management of disorders under E72.89 often requires a multidisciplinary approach, including:

  • Dietary Management: Patients may need to follow specialized diets that restrict certain amino acids or provide medical foods designed to supply essential nutrients without exacerbating metabolic imbalances.
  • Supplementation: In some cases, supplementation with specific amino acids or other nutrients may be necessary to prevent deficiencies and support metabolic function.
  • Monitoring and Support: Regular monitoring of metabolic status and developmental progress is crucial, along with supportive care to address any complications that arise.

Conclusion

ICD-10 code E72.89 encompasses a variety of disorders related to amino acid metabolism that do not fit into more specific categories. These disorders can have significant clinical implications, necessitating careful diagnosis and management to optimize patient outcomes. Understanding the nuances of these conditions is essential for healthcare providers to deliver effective care and support to affected individuals.

Approximate Synonyms

ICD-10 code E72.89 refers to "Other specified disorders of amino-acid metabolism." This classification encompasses a variety of metabolic disorders that affect the metabolism of amino acids, which are the building blocks of proteins. Here are some alternative names and related terms associated with this code:

Alternative Names

  1. Amino Acid Metabolism Disorders: A broad term that includes various conditions affecting how the body processes amino acids.
  2. Amino Acid Disorders: This term is often used interchangeably with amino acid metabolism disorders and can refer to specific conditions or a general category.
  3. Amino Acid Deficiencies: Conditions where the body lacks specific amino acids due to metabolic issues.
  4. Amino Acid Toxicity Disorders: Disorders that arise from the accumulation of certain amino acids in the body, often due to metabolic dysfunction.
  1. Metabolic Disorders: A general category that includes any disorder affecting metabolism, including those related to amino acids.
  2. Inherited Metabolic Disorders: Many amino acid metabolism disorders are genetic, falling under this broader category.
  3. Phenylketonuria (PKU): A specific disorder of amino acid metabolism that is often discussed in relation to other amino acid disorders.
  4. Maple Syrup Urine Disease (MSUD): Another specific condition that affects amino acid metabolism, often included in discussions of E72.89.
  5. Urea Cycle Disorders: A group of metabolic disorders that can also involve amino acid metabolism, as they affect the body's ability to remove ammonia, a byproduct of amino acid breakdown.

Clinical Context

Disorders classified under E72.89 can vary widely in their symptoms and severity, and they may require specific dietary management or medical treatment. Understanding these alternative names and related terms can help healthcare professionals communicate more effectively about these conditions and ensure appropriate diagnosis and treatment.

In summary, E72.89 encompasses a range of disorders related to amino acid metabolism, and recognizing the various terms associated with it can enhance clarity in clinical discussions and documentation.

Diagnostic Criteria

The ICD-10 code E72.89 refers to "Other specified disorders of amino-acid metabolism." This classification encompasses a variety of metabolic disorders that affect the metabolism of amino acids, which are the building blocks of proteins. Diagnosing these disorders typically involves a combination of clinical evaluation, biochemical testing, and genetic analysis. Below are the key criteria and methods used for diagnosis:

Clinical Evaluation

  1. Patient History: A thorough medical history is essential. Clinicians will inquire about symptoms, family history of metabolic disorders, and any previous diagnoses. Symptoms may vary widely depending on the specific disorder but can include developmental delays, neurological issues, or metabolic crises.

  2. Physical Examination: A comprehensive physical examination can reveal signs indicative of metabolic disorders, such as growth abnormalities, neurological deficits, or distinctive physical features associated with specific amino acid disorders.

Biochemical Testing

  1. Blood Tests: Blood samples are analyzed for amino acid levels. Elevated or decreased levels of specific amino acids can indicate a metabolic disorder. For example, phenylketonuria (PKU) is characterized by elevated phenylalanine levels.

  2. Urine Tests: Urine tests can also be performed to detect abnormal metabolites. Certain disorders may lead to the excretion of specific amino acids or their derivatives in the urine.

  3. Enzyme Activity Tests: In some cases, measuring the activity of specific enzymes involved in amino acid metabolism can help confirm a diagnosis. Deficiencies in these enzymes can lead to the accumulation of toxic metabolites.

Genetic Testing

  1. Molecular Genetic Testing: Genetic testing can identify mutations in genes associated with amino acid metabolism disorders. This is particularly useful for confirming diagnoses when biochemical tests suggest a specific disorder.

  2. Carrier Testing: For families with a history of metabolic disorders, carrier testing can determine if family members carry mutations that could lead to the disorder in offspring.

Differential Diagnosis

  1. Exclusion of Other Conditions: It is crucial to rule out other conditions that may present with similar symptoms. This may involve additional testing and consultations with specialists in metabolic disorders.

  2. Referral to Specialists: In complex cases, referral to a metabolic specialist or geneticist may be necessary for comprehensive evaluation and management.

Conclusion

Diagnosing disorders classified under ICD-10 code E72.89 involves a multifaceted approach that includes clinical assessment, biochemical testing, and genetic analysis. Each specific disorder may have unique diagnostic criteria, but the overarching goal is to identify abnormalities in amino acid metabolism to guide appropriate treatment and management strategies. Early diagnosis is critical, as many of these disorders can lead to significant health issues if left untreated.

Treatment Guidelines

ICD-10 code E72.89 refers to "Other specified disorders of amino-acid metabolism," which encompasses a variety of metabolic conditions that affect the body's ability to process amino acids. These disorders can lead to a range of health issues, including developmental delays, neurological problems, and metabolic crises. The treatment approaches for these conditions are often tailored to the specific disorder and the individual patient's needs. Below is an overview of standard treatment strategies.

Overview of Amino Acid Metabolism Disorders

Amino acid metabolism disorders can arise from genetic mutations affecting enzymes responsible for amino acid synthesis or breakdown. Common examples include phenylketonuria (PKU), maple syrup urine disease (MSUD), and tyrosinemia. Each disorder has unique implications for dietary management and medical treatment.

Standard Treatment Approaches

1. Dietary Management

Protein Restriction: Many amino acid metabolism disorders require a diet low in specific amino acids. For instance, individuals with PKU must adhere to a strict low-phenylalanine diet to prevent toxic accumulation[1].

Specialized Formulas: Patients may need to use medical foods or specialized formulas that provide essential nutrients without the harmful amino acids. These formulas are designed to meet the nutritional needs while avoiding specific dietary triggers[2].

Regular Monitoring: Frequent monitoring of amino acid levels in the blood is crucial. This helps in adjusting dietary intake and ensuring that patients remain within safe metabolic ranges[3].

2. Supplementation

Amino Acid Supplements: In some cases, patients may require supplementation with specific amino acids that are deficient due to dietary restrictions. For example, individuals with certain disorders may need to supplement with tyrosine or other non-essential amino acids[4].

Vitamins and Minerals: Supplementation with vitamins and minerals may also be necessary, particularly if dietary restrictions lead to deficiencies. For instance, patients may need additional B vitamins, which play a role in amino acid metabolism[5].

3. Medical Management

Enzyme Replacement Therapy: For some disorders, enzyme replacement therapy may be an option. This treatment involves administering the missing or deficient enzyme to help metabolize amino acids properly. However, this approach is not universally applicable to all amino acid metabolism disorders[6].

Medications: In certain cases, medications may be prescribed to manage symptoms or complications associated with amino acid metabolism disorders. For example, medications that help control seizures may be necessary for patients with neurological manifestations[7].

4. Genetic Counseling

Family Planning: Genetic counseling is recommended for families affected by amino acid metabolism disorders. This can provide information on the inheritance patterns, risks for future children, and options for prenatal testing[8].

Support and Education: Counseling can also help families understand the disorder, its management, and the importance of adherence to dietary and medical recommendations[9].

Conclusion

The management of disorders classified under ICD-10 code E72.89 involves a multifaceted approach that includes dietary modifications, supplementation, medical management, and genetic counseling. Each treatment plan should be individualized based on the specific disorder and the patient's unique needs. Regular follow-up with healthcare providers is essential to monitor the condition and adjust treatment as necessary. For those affected, a comprehensive care team, including dietitians, geneticists, and metabolic specialists, can significantly improve outcomes and quality of life.

By adhering to these treatment strategies, individuals with amino acid metabolism disorders can lead healthier lives while minimizing the risk of complications associated with their conditions.

Related Information

Clinical Information

  • Neurological issues common in amino-acid metabolism
  • Metabolic crises triggered by illness or fasting
  • Failure to thrive in infants and children
  • Gastrointestinal issues during metabolic crises
  • Skin rashes due to abnormal amino acid levels
  • Behavioral changes linked to neurological involvement
  • Muscle weakness a sign of certain disorders
  • Age of onset varies from infancy to adulthood
  • Family history often positive for inherited conditions
  • Certain disorders more prevalent in specific ethnic groups
  • Dietary restrictions crucial for managing the condition

Description

  • Disorders affect amino acid processing
  • Accumulation of toxic metabolites occurs
  • Deficiency in essential amino acids leads to clinical manifestations
  • Neurological symptoms include developmental delays and seizures
  • Metabolic crises involve vomiting, lethargy, and hypoglycemia
  • Growth and development issues occur due to inadequate nutrient absorption
  • Dermatological manifestations may present as skin rashes

Approximate Synonyms

  • Amino Acid Metabolism Disorders
  • Amino Acid Disorders
  • Amino Acid Deficiencies
  • Amino Acid Toxicity Disorders
  • Metabolic Disorders
  • Inherited Metabolic Disorders
  • Phenylketonuria (PKU)
  • Maple Syrup Urine Disease (MSUD)
  • Urea Cycle Disorders

Diagnostic Criteria

Treatment Guidelines

  • Protein restriction may be necessary
  • Specialized formulas for dietary management
  • Regular monitoring of amino acid levels
  • Amino acid supplements if deficient
  • Vitamins and minerals supplementation
  • Enzyme replacement therapy in some cases
  • Medications to manage symptoms

Related Diseases

Ritscher-Schinzel syndrome Holzgreve-Wagner-Rehder Syndrome 3MC syndrome 1 3MC syndrome 2 Yunis-Varon syndrome Nance-Horan syndrome ethylmalonic encephalopathy dicarboxylic aminoaciduria Prieto syndrome Miles-Carpenter syndrome syndromic X-linked intellectual disability Abidi type Griscelli syndrome type 2 Pierson syndrome D-mannitol allergy philophthalmiasis obsolete peripheral dysostosis mulibrey nanism Danon disease Liddle syndrome Gamstorp-Wohlfart syndrome obsolete SC phocomelia syndrome obsolete Saldino-Noonan syndrome obsolete Majewski syndrome obsolete infantile onset spinocerebellar ataxia Walker-Warburg syndrome L-2-hydroxyglutaric aciduria D-2-hydroxyglutaric aciduria glycogen storage disease XV ABCD syndrome ADULT syndrome triple-A syndrome Aland Island eye disease Allan-Herndon-Dudley syndrome anauxetic dysplasia 1 Bart-Pumphrey syndrome biotin-responsive basal ganglia disease Bjornstad syndrome Boomerang dysplasia childhood electroclinical syndrome AGAT deficiency methylmalonic aciduria and homocystinuria type cblD serine deficiency PHGDH deficiency PSPH deficiency tyrosinemia type II tyrosinemia type III Chanarin-Dorfman syndrome methylmalonic aciduria and homocystinuria type cblE methylmalonic aciduria and homocystinuria type cblG congenital intrinsic factor deficiency X-linked monogenic disease Qazi Markouizos syndrome obsolete CLN3 disease adenylosuccinase lyase deficiency ARC syndrome midface dysplasia rapadilino syndrome schneckenbecken dysplasia Meckel syndrome cone dystrophy Kahrizi syndrome mucopolysaccharidosis IX urofacial syndrome Perrault syndrome Marshall-Smith syndrome Koolen de Vries syndrome IMAGe syndrome spastic ataxia 3 spastic ataxia 7 X-linked hereditary ataxia spinocerebellar ataxia type 37 obsolete artemis deficiency janus kinase-3 deficiency coronin-1A deficiency gluten allergy alpha chain disease Kennedy's disease GABA aminotransferase deficiency gamma-amino butyric acid metabolism disorder homocarnosinosis Baraitser-Winter syndrome MASA syndrome Simpson-Golabi-Behmel syndrome type 1 rippling muscle disease 2 pontocerebellar hypoplasia type 1A pontocerebellar hypoplasia type 1B pontocerebellar hypoplasia type 2A pontocerebellar hypoplasia type 2C pontocerebellar hypoplasia type 4 pontocerebellar hypoplasia type 5 pontocerebellar hypoplasia type 6 omodysplasia syndromic X-linked intellectual disability Rapp-Hodgkin syndrome mitochondrial complex V (ATP synthase) deficiency nuclear type 4 CEDNIK syndrome acrorenal syndrome adenine phosphoribosyltransferase deficiency Stormorken syndrome Vici syndrome orofaciodigital syndrome IV orofaciodigital syndrome V acrofacial dysostosis, Catania type chromosome 10q23 deletion syndrome chromosome 16p12.1 deletion syndrome chromosome 3q29 microdeletion syndrome Cole-Carpenter syndrome Goldberg-Shprintzen syndrome Perry syndrome Pitt-Hopkins syndrome crab allergy Barber-Say syndrome Kufor-Rakeb syndrome

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.